Colorectal Cancer

Handling the Leucovorin Shortage
On July 20, the US Food and Drug Administration (FDA) announced shortages of leucovorin for injection. One manufacturer, Bedford, has not supplied a reason for the shortage or a date when supplies will be available. The other manufacturer, Teva, has cited manufacturing delays and provided an estimated release date in the fourth quarter of 2010.
 
Multivitamin Use Does Not Improve Outcomes in Colon Cancer
Multivitamin use during and after adjuvant chemotherapy did not reduce the risk of cancer recurrence or mortality in patients with stage III colon cancer, according to recently released findings of Cancer and Leukemia Group B (CALGB) 89803. Multivitamin use, however, also did not impact patients’ health negatively.
 
Type 2 Diabetes Associated with Colorectal Cancer in Men
Researchers identified an association between type 2 diabetes and colorectal cancer (CRC) among men. The association did not hold for women. The new study, published in the October issue of Gastroenterology, found that the risk existed regardless of insulin use. Insulin use, in fact, was found to be associated with a slight but not substantially increased risk of CRC.